Evidence-based clinical review Polypharmacy at the End of Life: Why Are So Many Patients Still Taking Statins and Bisphosphonates? A prognosis- and goals-based approach to preventive medications, with important exceptions for recent ASCVD, high fracture risk, and active cancer indications Estimated
Tag: end of life care
Reimagining Code Status in the 80+ Population: Beyond ‘Full Code’ vs ‘DNR.’
Reimagining Code Status in the 80+ Population: Beyond ‘Full Code’ vs ‘DNR.’ Review Abstract The traditional binary approach to code status decisions in patients over 80 years old fails to address the complex medical and ethical considerations inherent in this vulnerable population. This paper examines
